PRESCRIBING · PART D · 2024
Total Rx claims
248
Beneficiaries
—
Total drug cost
$70K
Distinct drugs
9
Brand share
37.5%
Top prescribed drugs
Estradiol74 claims
Ibandronate Sodium36 claims
Mirabegron28 claims
Vibegron28 claims
Ospemifene24 claims
QUALITY · MIPS · 2024
No data available for this provider in 2024.
CROSS-REFERENCE